A weak start

The overall cannabis sector was off to a weak start this week. The weakness was reflected in the Horizons Marijuana Life Sciences ETF (HMMJ), which sank by nearly 1.4%, and the ETFMG Alternative Harvest ETF (MJ), which fell 1.1% in the first half of the day on Monday.

Cannabis Stocks Fell despite Biden’s Support of Legalization

Worst performers

While most of the cannabis stocks were trading in the negative territory, the worst performers included KushCo Holdings (KSHB), which was trading lower by about 4% around 12:00 PM EST. Two other US-based stocks, Innovative Industrial Properties (IIPR) and Green Thumb Industries (GTBIF) were also in the bottom with a decline of about 3.5% and 1.4%, respectively.

Just last week, presidential candidate Joe Biden showed his support for marijuana legalization, which brought some hope to the cannabis sector in the US. His support was a big shift from his prior stance. Joe Biden had long opposed marijuana legalization. At a recent opioid epidemic forum, Joe Biden appeared to support the anti-marijuana camp.

Some of the other worst performers in the sector included Canopy Growth (WEED), which was trading lower by nearly 1.9%, and Aurora Cannabis (ACB), which was down about 2.1% as of noon.

Latest articles

Apple (AAPL) investors have had a roller coaster week. Apple stock has lost just under 2% in a week, ending on August 23, 2019.

Competition taking a toll on Netflix as its share of US subscription video streaming market keep falling as rivals gain ground.

Crude oil production continues to rise, and oil prices remain at $50. Despite that, US energy stocks aren’t getting investors’ interest.

Apple stock fell 4.6% as the US-China trade war intensified today. China warned of tariffs on more US goods, followed by Trump's tweeted response.

In response to new tariffs from China and President Trump's tweets, the market tanked to session lows on Friday. The DJIA nosedived more than 600 points.

Coverage on Cresco Labs has increased from seven analysts in July to nine in August. Six analysts favor a “strong buy,” and three recommend a “buy.”